| Literature DB >> 11435313 |
K Podar1, Y T Tai, F E Davies, S Lentzsch, M Sattler, T Hideshima, B K Lin, D Gupta, Y Shima, D Chauhan, C Mitsiades, N Raje, P Richardson, K C Anderson.
Abstract
Multiple myeloma (MM) remains incurable, with a median survival of 3 to 4 years. This study shows direct effects of vascular endothelial growth factor (VEGF) upon MM and plasma cell leukemia (PCL) cells. The results indicate that VEGF triggers tumor cell proliferation via a protein kinase C (PKC)-independent Raf-1-MEK-extracellular signal-regulated protein kinase pathway, and migration via a PKC-dependent pathway. These observations provide the framework for novel therapeutic strategies targeting VEGF signaling cascades in MM.Entities:
Mesh：
Substances：
Year: 2001 PMID： 11435313 DOI： 10.1182/blood.v98.2.428
Source DB: PubMed Journal: Blood ISSN： 0006-4971 Impact factor: 22.113